CNTB

Connect Biopharma Holdings

CNTB

Market cap $92M

1.65 USD

--0.06

3.51%

At close Updated Nov 3, 4:00 PM EST

Pre-market

After hours

1.73

+0.08

4.85%

1 day

-3.51%

5 days

1.23%

1 month

10.74%

3 months

-19.12%

6 months

108.86%

Year to date

36.36%

1 year

37.5%

5 years

-91.08%

10 years

-91.08%

About: Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

Employees: 62

Healthcare Biotechnology